
German biotech IDT Biologika has become the third company in the country to secure approval from the nation’s vaccine regulator …
IDT Biologika has said it plans to invest around 85 million euros in new production facilities and equipment in Germany …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

